Osteoarthritis Global Market 2024 - By Size, Demand, Share, Trends, Forecast To 2033

The Osteoarthritis Drug Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.

This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.

The key players in the osteoarthritis drug market include Alkem Laboratories, Anika Therapeutics, Inc., Bioventus, Inc., Chugai Pharmaceutical Co., Limited, Ferring B.V., Horizon Pharma plc, Pfizer Inc., Sanofi, Flexion Therapeutics, Inc. and Zimmer Biomet Holdings, Inc. among others.

An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Osteoarthritis Drug Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/osteoarthritis-drug-market/download-sampleMarket DynamicsThe market is gaining high demand on the account of the rapid increase in the count of the patients suffering from osteoarthritis.

The rise in R activities, availability of innovative & advanced treatments is further contributing the market growth.

On the flip side, the high cost of treatment is likely to hinder the growth of this market.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.

According to the new market research report by MarketsandMarkets, the osteoarthritis therapeutics market is estimated at $6.8 billion in 2019 and projected to reach $10.1 billion by 2024 at a CAGR of 8.1 percent from 2019 to 2024.

This growth, the report says, is in part due to the rapid increase in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease.Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease.

Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209565994Knee segment to witness the highest growth during the forecast periodBased on anatomy, the market is segmented into knee, hip, hand, and small-joint.

The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period.

This is attributed to a large number of patients suffering from knee osteoarthritis.Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018Based on drug type, the market is segmented into viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids.

The viscosupplementation agents segment accounted for the largest market share in 2018.

Osteoarthritis Market Analysis, By Type (Hip Osteoarthritis, Spinal Osteoarthritis) By Diagnosis  (Imaging, Joint Fluid Analysis) By Treatment (Medication, Surgery, Therapy) By End Users (Hospitals, Medical Institutes) - Global Forecast till 2023The Global Osteoarthritis Market Analysis shows market is touted to register a CAGR of 6.8% during the forecast period (2017-2023).The surge in the global osteoarthritis market is mainly due to the growing geriatric population, surging demand for minimally invasive surgical procedures, and high prevalence of osteoarthritis across the globe.

It is considered one of the most common joint disease, generally found in people of more than 65 years.

According to the WHO, osteoarthritis is considered one of the ten most disabling diseases, especially in the developed economies.Increased demand for minimally invasive surgical procedures in order to treat osteoarthritis is the primary factor triggering the demand from the osteoarthritis market.

For instance, MAKOplasty is a minimally invasive knee surgery, which helps to relieve pain caused by osteoarthritis.

Government support for funding and ongoing research and development are further creating new growth opportunities for the market.On the contrary, low per capita income, especially in the developing economies, coupled with the side effects associated with the treatment procedures are likely to restrict the market growth in the coming years.Osteoarthritis Market Competitive DashboardThe top players operating in the osteoarthritis market include Novartis AG (Europe), Abbott.

(U.S.), Eli Lilly and Company.

 The new market study by Precise Market Intelligence (PMI) provides in-depth analysis and projects the trajectory of the global Osteoarthritis Therapeutics market between 2020 and 2027.

The research report postulates several macro-economic factors ranging from government decisions, changing consumer preferences, etc.

to significant trends that are likely to influence the growth of the global Osteoarthritis Therapeutics market in the forthcoming years.

This report maps the impact of each market dynamic, such as drivers, trends, and restraints, on every segment and the involved stakeholders of the Osteoarthritis Therapeutics market.

The understanding of the impact on each segment bolsters stakeholders – including manufacturers, suppliers, and retailers – to develop strategies to leverage the forthcoming changes in the Osteoarthritis Therapeutics landscape.PMI’s analysts have compiled a comprehensive report using modern-day research methods that paints a transparent picture of the direction the market is headed in and will aid players in making the right decisions.For More Insights Into The Market, Request a Sample of This Report@ https://www.precisemarketintelligence.com/sample/12  Impact of COVID-19 on Osteoarthritis Therapeutics MarketThe unforeseen outbreak of COVID-19 has brought the global Healthcare sector to a screeching halt, and the Osteoarthritis Therapeutics market is no exception.

Perils of the pandemic such as halted productions disrupted supply chains, and depreciation in demand for Healthcare have led to a downtrend in the growth trajectory of the Osteoarthritis Therapeutics market.